Detalles de la búsqueda
1.
Novel treatment options in the management of metastatic castration-naïve prostate cancer; which treatment modality to choose?
Ann Oncol
; 30(10): 1591-1600, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31340031
2.
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.
Ann Oncol
; 26(4): 743-749, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25515657
3.
Liquid biopsies and plasma DNA: paving the way for personalized medicine in metastatic castration-resistant prostate cancer.
Ann Oncol
; 28(7): 1408-1409, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28459972
4.
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer.
Eur J Cancer
; 51(17): 2562-9, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26278646
5.
Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer.
Eur J Cancer
; 49(18): 3821-30, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24200698
Resultados
1 -
5
de 5
1
Próxima >
>>